This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cornelius, A. S. Articles by Spector, A. A. Search for Related Content PubMed PubMed Citation Articles by Cornelius, A. S. Articles by Spector, A. A.

Cytotoxic Effect of cis-Parinaric Acid in Cultured Malignant Cells¹

Division of Hematology/Oncology, Department of Pediatrics [A. S. C., D. A. K.], and Department of Biochemistry [N. R. Y., A. A. S.], University of Iowa College of Medicine, Iowa City, Iowa 52242

Parinaric acid, a naturally occurring 18-carbon fatty acid containing 4 conjugated double bonds, is toxic to human monocytic leukemia cells at concentrations of 5 µM or less. Conditioning of the medium reduces the cytotoxic effect, suggesting that parinaric acid and not a metabolite is the active agent. The mechanism of parinaric acid toxicity appears to involve lipid peroxidation because the toxic action can be blocked by the addition of butylated hydroxytoluene. When U-937 cells are differentiated to the monocytic form, they become resistant to as much as 30 µM parinaric acid. This difference in sensitivity may be explained in part by the fact that the undifferentiated cells take up 3 to 4 times more parinaric acid. Concentrations of parinaric acid less than 5 µM are also toxic to human THP-1 monocytic leukemia, HL-60 human promyelocytic leukemia, and Y-79 human retinoblastoma cells. Measurements of protein synthesis indicate that differentiated U-937 cells, confluent cultures of human fibroblasts, bovine aortic endothelial cells, and CaCo-2 colonic mucosal cells are much less sensitive to parinaric acid than the malignant cell lines tested, suggesting that the cytotoxic action may be selective for rapidly growing malignant tumors. Thus, parinaric acid may be the prototype of a new class of lipid chemotherapeutic agents that contain a conjugated system of double bonds and act by sensitizing tumor cells to peroxidation.

¹ This work was supported by NIH Grant HL39308.

² To whom requests for reprints should be addressed, at Department of Pediatrics, Division of Hematology and Oncology, 2514 JCP University of Iowa Hospitals and Clinics, University of Iowa, Iowa City, IA 52242.

Received 6/ 5/91. Accepted 9/ 9/91.

This article has been cited by other articles:

				S. Sturlan, M. Baumgartner, E. Roth, and T. Bachleitner-Hofmann Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells Blood, June 15, 2003; 101(12): 4990 - 4997. [Abstract] [Full Text] [PDF]